IL6 and Alzheimer disease: Escrig et al. study shows that the inhibition of IL-6 trans-signaling partially rescues the AD-induced mortality and reverses AD-induced cognitive and emotional changes in AD animal models, presenting strong potentials as a powerful therapeutic target in AD (Escrig et al., 2019).